G01N 2333/08
Rna viruses
Official title: RNA viruses
G01N2333/08 (Rna viruses) appears on 1,739 US grants and 3,100 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,739
- Published applications
- 3,100
- Assignees
- 1,512
- Inventors
- 7,130
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 6 | 0 |
| 1996 | 13 | 0 |
| 1997 | 39 | 0 |
| 1998 | 51 | 0 |
| 1999 | 33 | 0 |
| 2000 | 34 | 0 |
| 2001 | 42 | 9 |
| 2002 | 23 | 32 |
| 2003 | 32 | 69 |
| 2004 | 29 | 58 |
| 2005 | 23 | 97 |
| 2006 | 30 | 86 |
| 2007 | 38 | 68 |
| 2008 | 35 | 80 |
| 2009 | 51 | 80 |
| 2010 | 50 | 124 |
| 2011 | 47 | 103 |
| 2012 | 43 | 88 |
| 2013 | 58 | 86 |
| 2014 | 62 | 89 |
| 2015 | 66 | 120 |
| 2016 | 75 | 124 |
| 2017 | 83 | 123 |
| 2018 | 94 | 119 |
| 2019 | 110 | 107 |
| 2020 | 84 | 107 |
| 2021 | 82 | 199 |
| 2022 | 71 | 227 |
| 2023 | 76 | 333 |
| 2024 | 82 | 285 |
| 2025 | 70 | 178 |
| 2026 | 84 | 109 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2333/15RetroviridaeIndexing code570
- G01N 2333/18TogaviridaeIndexing code384
- G01N 2333/11OrthomyxoviridaeIndexing code334
- G01N 2333/165CoronaviridaeIndexing code234
- G01N 2333/115ParamyxoviridaeIndexing code84
- G01N 2333/085PicornaviridaeIndexing code76
- G01N 2333/175BunyaviridaeIndexing code15
- G01N 2333/14ReoviridaeIndexing code14
All 9 subgroupsShow fewer
Recent patents
- Binding protein specific for the spike protein of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)6 Oct 2026US 12,754,184 B2Navigo Proteins GmbH
- Quinine and its use to generate innate immune response29 Sep 2026US 12,746,236 B2The Trustees of the University of Pennsylvania
- Lassa virus-specific nanobodies and methods of their use29 Sep 2026US 12,747,284 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Anti-human immunodeficiency virus-1 antibodies and methods for uses thereof29 Sep 2026US 12,747,285 B2Grifols Diagnostic Solutions Inc.
- Method for accumulating microscopic objects, and method for detecting microscopic objects using same29 Sep 2026US 12,748,113 B2University Public Corporation Osaka
- System and Method for Single Protein Detection by Digital Plasmonic Nanobubbles8 Oct 2026US 2026/0309704 A1Board of Regents, The University of Texas System
- Ace2 inhibition assay for evaluation of vaccine immunogenicity8 Oct 2026US 2026/0309709 A1Novavax, Inc.
- Identifying antibody virus-neutralization status8 Oct 2026US 2026/0309711 A1
- Tcr-mimic bispecific antibodies for hiv-11 Oct 2026US 2026/0297193 A1The Johns Hopkins University
- Methods for detecting rocahepevirus1 Oct 2026US 2026/0298928 A1Abbott Laboratories
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997
- High-affinity nucleic acid ligands that discriminate between theophylline and caffeine277US 5,580,737 ANeXstar Pharmaceuticals, Inc. · 1996